Abstract:A photocatalytic
decarboxylative radical conjugate addition–elimination–oxa-Michael
reaction of hydroxyalkylated carboxylic acids with cyclopentenones
is developed to construct diverse cyclopentanonyl-fused functionalized
5–7 membered cyclic ethers. The stereoselective synthetic strategy
is amenable to substructural variation, establishing a direct total
synthetic route to two diastereomers of C3-amino cyclopentyltetrahydrofuranyl-derived
potent HIV-1 protease inhibitors with low nanomolar IC50 values.
“…The successful application of darunavir in combination therapies has inspired the pursuit of improved syntheses of darunavir − and syntheses of derivatives with the potential for even greater potency (Figure ). − In this context, the seminal efforts of Ghosh and coworkers laid the foundation for structural aspects of darunavir and the domains where the structure could be modified. In 2023, Raines and coworkers modified the structure of darunavir by modifying the P2’ region with the use of a benzoborolone group (see 2a and 2b ) and demonstrated the utility of installing such groups as pharmacophores .…”
Section: Introductionmentioning
confidence: 99%
“…Reiser and coworkers changed the P2 domain of darunavir by the use of an ethereal bicyclic cyclopentyl system resulting in low nanomolar IC 50 values . Ghosh and coworkers have been leaders in this field with the development of a number of darunavir derivatives wherein the P2 domain has been changed to enhance drug efficacy. − In this context, darunavir derivative 5 was designed with modifications to the P1, P2, and P2’domains to enhance interactions with the active site of the HIV-1 protease.…”
“…The successful application of darunavir in combination therapies has inspired the pursuit of improved syntheses of darunavir − and syntheses of derivatives with the potential for even greater potency (Figure ). − In this context, the seminal efforts of Ghosh and coworkers laid the foundation for structural aspects of darunavir and the domains where the structure could be modified. In 2023, Raines and coworkers modified the structure of darunavir by modifying the P2’ region with the use of a benzoborolone group (see 2a and 2b ) and demonstrated the utility of installing such groups as pharmacophores .…”
Section: Introductionmentioning
confidence: 99%
“…Reiser and coworkers changed the P2 domain of darunavir by the use of an ethereal bicyclic cyclopentyl system resulting in low nanomolar IC 50 values . Ghosh and coworkers have been leaders in this field with the development of a number of darunavir derivatives wherein the P2 domain has been changed to enhance drug efficacy. − In this context, darunavir derivative 5 was designed with modifications to the P1, P2, and P2’domains to enhance interactions with the active site of the HIV-1 protease.…”
“…The photoinduced electron transfer chemistry has indeed brought forth an astoundingly diverse range of organic free radical and radical ion reactions with broad impact in organic synthesis, materials science and pharmaceutical chemistry. 3 Moreover, visible-light-mediated photoredox catalysis offers exciting opportunities to achieve challenging carbon–carbon and carbon–heteroatom bond formations under mild and ecologically benign conditions. 4 Over the past few years, photoredox-initiated reactions, catalyzed by transition metal complexes or organic dyes (organic photoredox catalysts), have brought an important revolution in organic synthesis.…”
Over the past decade, visible-light photoredox catalysis has blossomed as a powerful strategy and offers a discrete activation mode complementary to thermal controlled reactions. Visible-light-mediated photoredox catalysis also offers exciting...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.